ProtoKinetix

Business Services · Ohio, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

109 W Main St, Dalton, Ohio, 44618, Unit...

Phone Number

(330) 455-4971

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About ProtoKinetix

ProtoKinetix is a clinical-stage molecular biotechnology company that has developed and patented a family of hyper stable, potent glycopeptides (AAGP®) that enhance both engraftment and protection of transplanted cells, tissues and organs used in regenerative medicine. Due to the results achieved over the last four years of testing, the University of Alberta has begun Phase 1 human clinical trials. Additional studies will be expanded to include whole organ transplantation and all therapies that are being developed globally to date; diabetes, retinal degeneration, cardiac repair and many other degenerative conditions. In addition, the company is studying the potential impact on several cancer therapies.Explore more
ProtoKinetix's Social MediaPopular Searchesprotokinetix IncProtokinetixProto Kinetix IncProtoKinetix is aSIC Code 87,873NAICS Code 54,541Show more

ProtoKinetix Org Chart

Clarence Smith, Chief Executive Officer at ProtoKinetix
United States flag for contact location.

Chief Executive Officer

PhoneEmail
MG
United States flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is ProtoKinetix your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to ProtoKinetix

Compare insights from companies similar to ProtoKinetix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

ProtoKinetix

<$5M
1-10
Private
-
1999
<$5M
1-10
Public
-
2012
<$5M
11-50
Private
-
1996
MR
Michael RackleyVice President, Medical Device Business
<$5M
11-50
Private
-
-
<$5M
1-10
Private
<$5M
2005
AR
Armin ReitmairVice President, Translational Research Consulting
<$5M
11-50
Private
<$5M
2005
JL
Jos�� L��pezSenior Medical Director
<$5M
1-10
Private
-
2009
JN
Joseph NowoslawskiChief Operating Officer
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

ProtoKinetix is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

ProtoKinetix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ProtoKinetix.

ProtoKinetix Tech Stack

A closer look at the technologies used by ProtoKinetix

ProtoKinetix News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding ProtoKinetix

What is ProtoKinetix's official website?
ProtoKinetix's official website is www.protokinetix.com
What is ProtoKinetix's Revenue?
ProtoKinetix's revenue is <$5 Million
What is ProtoKinetix's SIC code?
ProtoKinetix's SIC: 87,873
What is ProtoKinetix's NAICS code?
ProtoKinetix's NAICS: 54,541
How many employees does ProtoKinetix have?
ProtoKinetix has 1-10 employees
What industry does ProtoKinetix belong to?
ProtoKinetix is in the industry of: Business Services, Research & Development
What is ProtoKinetix competition?
ProtoKinetix top competitors include: Essential Pharmaceuticals, HD Medical, Targazyme, Cell Source
What technology does ProtoKinetix use?
Some of the popular technologies that ProtoKinetix uses are: WordPress.org, PHP, Cloudflare Website Optimization, Google Universal Analytics
Who is the CFO of ProtoKinetix?
ProtoKinetix's CFO is Michael Guzzetta
How do I contact ProtoKinetix?
ProtoKinetix contact info: Phone number: (330) 455-4971 Website: www.protokinetix.com
What does ProtoKinetix do?

ProtoKinetix is a clinical-stage molecular biotechnology company that has developed and patented a family of hyper stable, potent glycopeptides (AAGP®) that enhance both engraftment and protection of transplanted cells, tissues and organs used in regenerative medicine. Due to the results achieved over the last four years of testing, the University... of Alberta has begun Phase 1 human clinical trials. Additional studies will be expanded to include whole organ transplantation and all therapies that are being developed globally to date; diabetes, retinal degeneration, cardiac repair and many other degenerative conditions. In addition, the company is studying the potential impact on several cancer therapies.Read More

What are ProtoKinetix social media links?
ProtoKinetix Linkedin page ProtoKinetix Twitter page ProtoKinetix Facebook page
Is ProtoKinetix a public company?
ProtoKinetix is private company therefore does not currently have an official ticker symbol
See more information about ProtoKinetix

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.